This cohort study is a large population-based study in the UK to determine the risks of comorbid mental health conditions (including depression, anxiety and other potential psychological complications of vitiligo) in adults with vitiligo compared to controls and to evaluate whether the relative risks may vary by different ethnicity.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Participants With Depressive Episodes
Timeframe: At the time of diagnosis in all people diagnosed with vitiligo 2004-2020 inclusive. For matched controls, the date of diagnosis of their matched case.
Risk of Depressive Episodes Within Adult Patients With Vitiligo
Timeframe: Within two years of vitiligo diagnosis. For matched controls, within two years of the date of diagnosis of their matched case.
Number of Participants With Anxiety Disorder
Timeframe: At the time of diagnosis in all people diagnosed with vitiligo 2004-2020 inclusive. For matched controls, the date of diagnosis of their matched case.
Number of Participants With Recurrent Depressive Disorder
Timeframe: At the time of diagnosis in all people diagnosed with vitiligo 2004-2020 inclusive. For matched controls, the date of diagnosis of their matched case.
Risk of Anxiety Disorder Within Adult Patients With Vitiligo
Timeframe: Within two years of vitiligo diagnosis. For matched controls, within two years of the date of diagnosis of their matched case.
Risk of Recurrent Depressive Disorder Within Adult Patients With Vitilgo
Timeframe: Within two years of vitiligo diagnosis. For matched controls, within two years of the date of diagnosis of their matched case.